Contagious order as a risk factor for liver fibrosis progression in co-infection with human immunodeficiency virus, hepatitis B and C viruses

QR Code

Contagious order as a risk factor for liver fibrosis progression in co-infection with human immunodeficiency virus, hepatitis B and C viruses

In triple co-infection with HIV/HCV/HBV, the prognosis is significantly poorer and life expectancy is lower because of the rapid progression of liver fibrosis or development of hepatocellular carcinoma. The aim of this study was to test the hypothesis that one of the risk factors for the unfavorable...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. P. Feoktistova, D. Yu. Konstantinov, E. S. Malova, I. P. Balmasova
Format:	Article
Language:	Russian
Published:	Journal Infectology 2024-01-01
Series:	Журнал инфектологии
Subjects:	hiv/hcv/hbv co-infection order of pathogen acquisition progressive liver fibrosis
Online Access:	https://journal.niidi.ru/jofin/article/view/1571
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A new perspective on risk factors for progressive liver fibrosis in patients with HIV, HBV, HCV superinfection
by: E. P. Feoktistova, et al.
Published: (2024-10-01)

The characteristic of lethality as an indicator of combinad infections
by: V. V. Nechaev, et al.
Published: (2016-04-01)

External quality assessment for nucleic acid quantitative testing of human hepatitis B and hepatitis C virus in Chongqing, China: 2009–2024
by: Yuanyuan Guo, et al.
Published: (2025-09-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

Assessment of the Prevalence of Markers of Monoinfection with Hepatitis C Virus and Coinfection with Hepatitis C and B Viruses among the Personnel of Medical Institutions of an Endemic Region
by: M. P. Kostinov, et al.
Published: (2025-07-01)

Characterization of Hepatitis B Virus and Human Immunodeficiency Virus among HIV/HBV Co-Infected Patients from the Republic of Guinea
by: A. N. Shchemelev, et al.
Published: (2019-10-01)

Treatment of end-stages of liver disease in outcome of persistent hepatitis C virus infection at deficiency of donor organs
by: Ye. N. German, et al.
Published: (2011-03-01)

Living donor domino liver transplantation in a hepatitis C virus/human immunodeficiency virus-coinfected hemophilia patient: a case report
by: Hidekazu Yamamoto, et al.
Published: (2020-07-01)

Transplantation of organs from donors infected with blood-borne viral infections. The experience of foreign countries
by: M. Sh. Khubutiya, et al.
Published: (2016-12-01)

PATTERNS OF ADMISSIONS TO A GENERAL HOSPITAL IN PATIENTS WITH MIXED TYPES OF BLOOD-BORNE VIRAL INFECTIONS
by: S. A. Solonin, et al.
Published: (2016-12-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian Federation
by: N. V. Soboleva, et al.
Published: (2017-06-01)

Hepatocellular Carcinoma Prediction and early Diagnosis of Hepatitis B and C viral infection using miR-122 and miR-223 in a sample of Iraqi patients.
by: Saja Khudhier Essa Al-Juboori, et al.
Published: (2023-08-01)

HBV, HCV, and HDV Triple-Infection—A Therapeutic Challenge
by: Alexia Anastasia Stefania Balta, et al.
Published: (2025-05-01)

Diagnostic options of non-invasive assessment of fibrosis at diffuse liver diseases
by: I. Yu. Pirogova, et al.
Published: (2009-08-01)

Hepatitis B Virus Genotypes and Subgenotypes Circulating in Belarus
by: Vladimir Eremin, et al.
Published: (2025-06-01)

Progress towards a hepatitis C virus vaccine
by: Lok Man John Law, et al.
Published: (2013-01-01)

ROLE OF HEPATITIS C VIRUS COINFECTION IN VIOLATION OF PRODUCTIVE THYMIC FUNCTION IN HIV-INFECTED PATIENTS UNDER IMMUNOLOGICALLY INEFFICIENT ANTIRETROVIRAL THERAPY
by: E. V. Saidakova, et al.
Published: (2014-07-01)

Features of clinical course of chronic hepatites of mixed viral (HBV+HCV) etiologies
by: G. K. Mirodzhov, et al.
Published: (2009-10-01)

The comparative description of clinical course, injury an regeneration of liver while chronic HBV- and HCV- infections course
by: V. E. Karev, et al.
Published: (2014-09-01)

Dynamic changes in the prevalence of markers of hepatitis C virus infection among the conditionally healthy population of the Tyva Republic
by: A. A. Saryglar, et al.
Published: (2024-01-01)

Variety of the hepatitis B virus genovariants in the military
by: Yu. V. Ostankova, et al.
Published: (2019-10-01)

Prevalence of Serological and Molecular-Biological HIV-Infection, HBV and HCV Markers among Medical Workers
by: E. V. Anufrieva, et al.
Published: (2024-12-01)

THE PROBLEMS OF PROVIDING INFECTIOUS DISEASE SAFETY FOR ORGAN AND TISSUE DONATION BY SCREENING BLOOD-BORNE VIRAL INFECTIONS
by: M. Sh. Khubutiya, et al.
Published: (2016-04-01)

Hyperendemicity and genotype diversity of hepatitis B virus among patients attending the University of Abuja Teaching Hospital, Nigeria
by: Ugwu, Chinwe Ndidi, et al.
Published: (2025-07-01)

Prevalence of Markers of Certain Blood-Borne Viral Infections in Pregnant Women and Their Partners in the Republic of Guinea
by: T.A. L. Balde, et al.
Published: (2023-10-01)

Personality Disorders in Patients with Human Immunodeficiency Virus
by: Abbas Boosazar, et al.
Published: (2023-05-01)

Psychosocial counseling when testing for human immunodeficiency virus: what to focus on?
by: O. V. Koltsova, et al.
Published: (2021-02-01)

Validation of albumin platelet product as a non-invasive fibrosis staging tool in patients with chronic HCV-related liver disease
by: Maha Elsabaawy, et al.
Published: (2025-06-01)

HEPATOCELLULAR CARCINOMA. RECENT ADVANCES IN DIAGNOSIS AND TREATMENT
by: T. Y. Chernobrovkina, et al.
Published: (2016-03-01)

High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e‐antigen for the progression of liver fibrosis
by: Bianqiao Cheng, et al.
Published: (2024-01-01)

Worsening of Controlled Attenuation Parameter and Metabolic Profile After HCV Cure in People with HIV as a Sign of Steatosis
by: Alessia Siribelli, et al.
Published: (2025-06-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

Molecular-genetic pathways of hepatitis C virus regulation of the expression of cellular factors PREB and PLA2G4C, which play an important role in virus replication
by: E. L. Mishchenko, et al.
Published: (2023-12-01)

Drug-induced lesion of the liver: general-purpose morphological markers
by: V. T. Ivashkin, et al.
Published: (2009-03-01)

Polymorphisms of interferon γ and NKG2D receptor genes in predicting vertical transmission of HIV/HCV coinfection
by: A. A. Khamatova, et al.
Published: (2023-12-01)

The experience of the Moscow City Center for AIDS Prevention and Treatment of using glecaprevir/pibrentasvir in patients with HIV/HCV coinfection
by: A. I. Mazus, et al.
Published: (2021-12-01)

THE CASE OF TRAUMATIC TRANSMISSION CHILD OF HUMAN IMMUNODEFICIENCY VIRUS
by: Yu. V. Ostankova, et al.
Published: (2016-12-01)

A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
by: A. A. Ostanin, et al.
Published: (2014-07-01)

ANTIRETROVIRAL ROLE IN TUBERCULOSIS PREVENTION AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (RETROSPECTIVE COHORT CLINICAL STUDY)
by: Z. M. Zagdyn, et al.
Published: (2018-04-01)